Skip to main content

Energy

Iran missile strikes spark risk repricing

The joint assault by Israel and the United States against Iran have sent shockwaves through global insurance markets, triggering risk repricing and renewed scrutiny of accumulation exposure across marine, aviation and specialty lines.

Insurers Review of the Year 2025

Insurers managed to post profits amid a softening market in 2025, invested in technology and pushed to reaffirm the industry’s vital role in protecting society with the Labour government and regulators.

Broker Review of the Year 2025

A softening market put downward pressure on brokers revenue in 2025 but businesses that embraced digital breakthroughs and delivered exceptional service have succeeded in holding on to their clients in a competitive market.

How insurance fuels the global shift to cleaner energy

As governments and activists call for faster climate action, Damisola Sulaiman digs deep into how the insurance industry is quietly enabling the net zero transition by unlocking investment, managing emerging risks, and helping high-emission sectors go…

Pen Underwriting’s plan to becoming biggest MGA

After Pen Underwriting hit a five-year goal of managing around £1bn of gross written premium a year ahead of schedule, Nick Wright, chief development officer, has revealed how the MGA will achieve £1.75bn by the end of this decade.

Big Interview: Andy Rice, Charles Taylor Adjusting

From a guitar-playing teenager to CEO of Charles Taylor Adjusting International, Andy Rice shares how his loss adjusting journey started in 1985 and outlines how he is orchestrating to growing the business globally in 2025.

Big Interview: Andrew McMellin, Markel

Andrew McMellin, president of Markel International, sits down with Harry Curtis to talk about the insurer’s plans to hit $5bn premium by 2030, rebalance its portfolio, and how it’s using AI to turn the distribution chain on its head.

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here